Cigarette smoking remained a major health concern over the review period, with the government further regulating cigarettes sales in India. As such, these movements benefited sales of NRT gum, the only category present in smoking cessation aids in the country. According to Euromonitor International’s Countries & Consumers data, smoking prevalence in India is set to fall from 11.9% in 2009 to 11.5% in 2020, with an increasing number of smokers trying to kick the habit.

Euromonitor International’s NRT Smoking Cessation Aids in India report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Why buy this report?* Get a detailed picture of the NRT Smoking Cessation Aids market;* Pinpoint growth sectors and identify factors driving change;* Understand the competitive environment, the market’s major players and leading brands;* Use five-year forecasts to assess how the market is predicted to develop.

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...